Couple-based psychosexual support following prostate cancer surgery: results of a feasibility pilot randomized control trial by Robertson, Jane et al.
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/93789/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Robertson, Jane, McNamee, Phillip, Molloy, Gerry, Hubbard, Gill, McNeill, Alan, Bollina, Prasad,
Kelly, Daniel M. and Forbat, Liz 2016. Couple-based psychosexual support following prostate
cancer surgery: results of a feasibility pilot randomized control trial. Journal of Sexual Medicine 13
(8) , pp. 1233-1242. 10.1016/j.jsxm.2016.05.013 file 
Publishers page: http://dx.doi.org/10.1016/j.jsxm.2016.05.013
<http://dx.doi.org/10.1016/j.jsxm.2016.05.013>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
A
rt
ic
le
 i
n
 P
re
ss
Couple-Based Psychosexual Support Following Prostate Cancer Surgery:
Results of a Feasibility Pilot Randomized Control Trial
Jane Robertson, PhD,1 Phillip McNamee, PhD,2 Gerry Molloy, PhD,3 Gill Hubbard, PhD,4 Alan McNeill, MD,5
Prasad Bollina, MD,5 Daniel Kelly, PhD,6 and Liz Forbat, PhD7
ABSTRACT
Introduction: Surgery for prostate cancer can result in distressing side effects such as sexual difﬁculties, which are
associated with lower levels of dyadic functioning. The study developed and tested an intervention to address
sexual, relational, and emotional aspects of the relationship after prostate cancer by incorporating elements of
family systems theory and sex therapy.
Aims: To develop and test the feasibility and acceptability of relational psychosexual treatment for couples with
prostate cancer, determine whether a relational-psychosexual intervention is feasible and acceptable for couples
affected by prostate cancer, and determine the parameters for a full-scale trial.
Methods: Forty-three couples were recruited for this pilot randomized controlled trial and received a six-session
manual-based psychosexual intervention or usual care. Outcomes were measured before, after, and 6 months
after the intervention. Acceptability and feasibility were established from recruitment and retention rates and
adherence to the manual.
Main Outcome Measures: The primary outcome measurement was the sexual bother subdomain of the
Expanded Prostate Cancer Index Composite. The Hospital Anxiety and Depression Scale and the 15-item
Systemic Clinical Outcome and Routine Evaluation (SCORE-15) were used to measure emotional and rela-
tional functioning, respectively.
Results: The intervention was feasible and acceptable. The trial achieved adequate recruitment (38%) and
retention (74%) rates. The intervention had a clinically and statistically signiﬁcant effect on sexual bother
immediately after the intervention. Small decreases in anxiety and depression were observed for the intervention
couples, although these were not statistically signiﬁcant. Practitioners reported high levels of adherence to the
manual.
Conclusion: The clinically signiﬁcant impact on sexual bother and positive feedback on the study’s feasibility
and acceptability indicate that the intervention should be tested in a multicenter trial. The SCORE-15 lacked
speciﬁcity for this intervention, and future trials would beneﬁt from a couple-focused measurement.
J Sex Med 2016;-:1e10. Copyright  2016, International Society for Sexual Medicine. Published by Elsevier Inc.
All rights reserved.
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INTRODUCTION
Prostate cancer is the most common form of cancer in men in
developed countries.1 More men are surviving prostate cancer
owing to earlier detection and improved treatment.2 Removing
the prostate gland (radical prostatectomy) is a dominant treat-
ment approach3; however, this surgery has a range of side effects,
with long-lasting sexual and urinary difﬁculties being the most
common.4 These effects can result in decreased quality of
life, anxiety, and depression5e7 and are enduring, because most
men have not returned to baseline sexual function 2 years after
surgery.8 Partners also can experience signiﬁcant psychological
distress,9e11 with sexual dysfunction negatively affecting
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partners’ views of their relationship and self.12,13 Rates of
psychological distress, including depressive symptoms, in part-
ners of men with prostate cancer are often found to be as high, or
even higher, than those of the patient.14
Couple cohesion is an important predictor of adjustment in
men after a diagnosis of prostate cancer. Erectile dysfunction is
associated with lower levels of dyadic adjustment after surgery,15
which can lead to severe disruption in relationships16 and
decreased well-being owing to the impact on couple intimacy
and communication.17 Therefore, viewing the couple as a rela-
tional system is important, with dyads who communicate openly
adjusting better to illness and disability.18 Understanding wider
family relationships can be important in supporting sexual
functioning in couples,19 and to address sexual issues it is critical
to support the relationship more generally.20
A systemic approach is supported by evidence demonstrating
that lack of couple communication, relationship problems, and
psychological distress are the psychosocial sequelae most
amenable to intervention in couples affected by cancer.21 Other
investigators have evaluated the efﬁcacy of psychosocial
interventions addressing sexual and relationship functioning in
men with prostate cancer.22 The most successful interventions
have been established as driven by a psychologist or a therapist,
delivered face to face, and containing the explicit use of sex
therapy techniques.23,24
Therefore, the present study developed a relational psycho-
sexual treatment for couples with prostate cancer (RiPSToP) that
combined a systems approach with elements of sex therapy to
enable the intervention to address broader relational issues that
affect speciﬁc problems concerning sex and intimacy.
AIMS
The primary aim of the study was to determine whether a
relational-psychosexual intervention is feasible and acceptable for
couples affected by prostate cancer. Subsidiary to this, the study
aimed to determine the parameters for a full-scale trial.
METHODS
Full methods have been reported elsewhere.25 Patients with
prostate cancer and their partners were recruited from a single
site in Edinburgh, Scotland, United Kingdom.
Participant Eligibility Criteria
Eligible patients were men who (i) were 11 weeks to 4 years
since surgery for prostate cancer (to recruit men who had
recovered from the surgery); (ii) had a partner who was willing to
take part in the trial (in an established same- or different-sex
relationship); (iii) scored no higher than 60 (the clinical
threshold for potency) on the sexual function domain of the
Expanded Prostate Cancer Index Composite (EPIC)26; (iv) had a
prognosis longer than 1 year based on clinical risk of dying of
prostate cancer drawing on the Scottish Cancer Taskforce (2014)
guidelines27; (v) could provide informed consent; (vi) could
communicate in English; and (vii) lived within traveling distance
of the intervention site (owing to the catchment area of the
clinic, patients who lived in the south-west of Scotland were
excluded from the study because it would not have been feasible
to travel).
Recruitment and Randomization
Patients attending follow-up completed a screening
questionnaire (EPIC) to assess eligibility on site or by postal
invitation from the clinical team. All eligible patients were
invited to complete this screening questionnaire. Consent was
gained by the researcher from eligible couples and baseline data
collected before the intervention (outcome measurements and
demographics) were returned by post. Subsequently, patients and
their partners were randomly assigned using block randomization
with a 1:1 allocation ratio. The allocation sequence was
computer generated in blocks of four. Randomization was carried
out by a research administrator who had no involvement in the
study. After randomization, participants were enrolled in the study
by the research team and advised of their allocation to the inter-
vention group or to standard care (usual follow-up hospital
appointments, without speciﬁc attention to psychosexual or rela-
tional function). Figure 1 shows the ﬂow of patients through
the study.
Recruitment ran from June 2013 to September 2014. Follow-
up ceased in June 2015, when the pilot study was completed.
Intervention: Relational Psychosexual Treatment for
Couples With Prostate Cancer
The intervention was comprised of assistance with emotional
disclosure,28,29 psychoeducation,14,23 relational and sexual
needs,23,24,30 and dyadic adjustment and coping.31,32 The
appropriate dose (six 50-minute sessions) was determined from
the literature.33,34 A treatment manual was developed to guide
and promote consistency in delivering the intervention35 and is
available from the corresponding author. The manual was
comprised of information about prostate cancer and its effects,
principles of therapeutic change, guidance on using the manual,
and a detailed session structure plan. The session structure is
presented in Table 1.
The manual was based on systemic principles18,36,37 com-
bined with techniques from sex therapy (ie, sensate focus).38 The
manual offered an intermediate level of speciﬁcity, enabling
practitioners to use their own therapeutic style and take some
lead from the couple, while meeting the objectives of the inter-
vention. Specialist training in delivery of the intervention was
provided to practitioners holding accredited counseling or
psychotherapy qualiﬁcations. Practitioners engaged in routine
clinical supervision throughout intervention delivery. The
intervention was delivered in the premises of a third-sector
J Sex Med 2016;-:1e10
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organization, rather than the clinical setting, and commenced as
soon as possible after recruitment.
Main Outcome Measures
All outcome measurements were self-reported and completed
at three time points: at baseline before the intervention (T0), at
the end of the intervention (or 4 months after baseline for con-
trols; T1), and 6 months after the end of the intervention (T2).
The EPIC, a 36-item measurement of health-related quality of
life in men with prostate cancer, was used.39 The primary outcome
measurement was the “sexual bother” subdomain score. This sub-
domain of the EPIC asks the patient to rate the extent of difﬁculty
(from “no problem” to “big problem”) associated with his level of
sexual desire, ability to have an erection, ability to achieve orgasm,
and overall sexual function (see Supplemental Materials).
Two secondary outcome measurements were the Hospital
Anxiety and Depression Scale (HADS)40 and the 15-item
Systemic Clinical Outcome and Routine Evaluation (SCORE-
15), a validated systemic therapy outcome measurement to assess
family functioning within therapy.41,42 The SCORE-15 includes
positive and negative items concerning strength and adaptability
(eg, “we trust each other”), disrupted communication (eg, “it
feels risky to disagree in our family”), and whether the family is
overwhelmed with difﬁculties (eg, “we ﬁnd it hard to deal with
everyday problems”). Patients and partners independently
reported on family interactions, indicating the level of difﬁculty
within their family and the level of similarity or difference in
perceptions within the couple.
A bespoke self-report questionnaire collected demographic
information.
Practitioner Fidelity to the Manual
Practitioners reported their adherence to the manual by
completing a scale of 0 to 10 for each sub-objective within each
w
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Figure 1. Recruitment ﬂow diagram. EPIC ¼ Expanded Prostate Cancer Index Composite; T1 ¼ end of intervention (or 4 months after
baseline for controls); T2 ¼ 6 months after end of intervention.
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session, thereby capturing the competence and depth of each
element of the intervention rather than purely whether the issue
had been discussed. Adherence was stressed in the preparatory
training session and in a further question-and-answer session
with the practitioners approximately midway through the inter-
vention to emphasize the importance of manual ﬁdelity.
Acceptability and Feasibility
A priori criteria43 were set to ensure there was a rationale for
concluding that the intervention was feasible and acceptable.
These criteria included establishing adequate recruitment and
retention rates of 29% and 72%, respectively (based on other
couple psychosexual interventions44); effective randomization
processes with comparable groups at baseline (T0); and clinically
signiﬁcant improvement on the primary outcome measurement.
Qualitative data also were gathered on trial procedures and
intervention content regarding their acceptability to participants.
These ﬁndings will be published elsewhere.
Data Analysis
This article reports clinical and statistical signiﬁcance. Mean-
ingful clinical change for the EPIC is considered 0.5 of SD from
each of the domain-speciﬁc scores of the validation cohort.30 For
sexual bother, this required a 15-point change (based on the
validation cohort having a mean score of 41.1, SD ¼ 30.1).
Therefore, observed differences between time points are reported
(in units of measurement) to give a preliminary estimate of the
clinical signiﬁcance of the intervention. The statistical signiﬁ-
cance level was set at an a level of 0.05. Repeated-measures
analysis of variance (two-way) was performed to identify trends
in outcome measurements and the effect size of the intervention
(partial h2). Fidelity to the manual was analyzed with descriptive
statistics. Data were managed and analyzed using SPSS 19 (SPSS,
Inc, Chicago, IL, USA).
Ethics
The U.K. National Health Service research ethics committee
granted the study a favorable opinion by the NHS West of
Scotland Research Ethics Committee (Reference: 12/WS/0255).
Written consent was gained from all study participants.
RESULTS
Figure 1 shows the ﬂow of participants through this trial. Of
the 401 men invited to participate in the study, 128 (32%)
returned the screening questionnaire and were assessed for
eligibility to the study. One hundred fourteen men met the
Table 1. Summary of the six-session intervention
Session number—main focus Content
Session 1—getting to know the couple:
orientation and engagement
This ﬁrst session outlined the support on offer. Topics for discussion included:
Couple’s deﬁnition of current issues, concerns and problems
Cancer diagnosis and treatment(s)
Partner’s role in the context of diagnosis and treatment mapping the support
network and wider family system
Session 2—couple’s communication
style and relationship
This session was focused primarily on understanding the patient and his partner as a
couple, to explore how they convey love, support, understanding, companionship and
affection.
Session 3—intergenerational patterns of
illness, coping, and affection
Focusing on intergenerational patterns, discussion centered on the role and meaning
of illness in the couple relationship in the context of:
Family resilience
Dyadic adjustment in ill health
Role of partners and family when someone is ill
How people in the family express intimacy
Session 4—couple intimacy before
and after cancer
The couple’s sexual relationship before and after cancer was explored.
A psychoeducational approach was used to promote closeness and express intimacy
after treatment. The place of medical treatments was considered and techniques
from sex therapy were applied if appropriate for the couple.
Session 5—further exploration of
emerging areas
This session focused on areas that emerged in previous sessions in which the
practitioner and couple wished to give more time. This included more work on
increasing levels of intimacy and improving satisfaction with sexual activity, with
discussion of successes or challenges therein.
Session 6—summarizing couple’s
accomplishments and future planning
The ﬁnal session summarized the work to date, with discussion of relapse prevention
and how to take forward progress that has been made, including the setting of
short- and long-term goals. This included a speciﬁc focus on maintaining intimacy
and dyadic adjustment.
J Sex Med 2016;-:1e10
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eligibility criteria. Forty-three couples were subsequently
recruited to the study, comprising 44 men and 42 women,
because there was one same-sex couple. This represents a
recruitment rate of 38% of eligible men who returned screening
questionnaires.
Eleven couples withdrew during the course of the study.
This represents a retention rate of 74%. Another two cou-
ples did not return their T2 scores within the project
timeframe.
Participant Characteristics
Participant characteristics and demographics are presented in
Table 2. The average age of the sample was 63.7 years and all
participants were white. The range of time since surgery was 2 to
46 months (mean ¼ 11.51 months). The duration of the couple
relationship ranged from 1 to 52 years (mean ¼ 35.62 years for
intervention couples, mean ¼ 28.64 years for control couples).
Couples tended to be from the least deprived areas of Scotland.45
Clinical risk of prostate-speciﬁc mortality was calculated drawing
on the Scottish Cancer Taskforce (2014) guidelines.27 Most men
(60%) were in the medium-risk category, with only 12% of men
being at high risk.
Analysis of the baseline data (independent-sample t-tests and
c
2 tests) indicated that randomization was successful, with no
signiﬁcant differences observed between the control and inter-
vention groups (Table 3).
Outcomes
Means, SDs, and ranges of scores are presented in Table 4 for
the primary and secondary outcome measurements (and relevant
subscales) at the three time points.
Results of the two-way analysis of variance showed signiﬁ-
cant variation in the primary outcome of sexual bother
(F2,50 ¼ 3.461, P ¼ .033). Therefore, pairwise comparisons
were conducted, and data between baseline and ﬁrst follow-up
(T1) were found to be signiﬁcantly different for men in
the intervention group (mean difference ¼ 12.27, 95%
CI ¼ 24.09 to 0.46, P ¼ .04). Comparisons between
T0 and T1 for men in the control group were statistically
insigniﬁcant. This result means that there was a signiﬁcant
difference on sexual bother for men randomized to the psy-
chosexual intervention group compared with men in the
usual-care group; this difference was not maintained at second
follow-up (T2). Further, those men assigned to the interven-
tion had an average increase in sexual bother score of 19.98
from T0 to T1. This exceeded the 15-point increase criteria
for minimally signiﬁcant change on the EPIC. Men in the
control group had an average increase of only 5.94. However,
this improvement for men who received the intervention was
not maintained; 6 months after the intervention, sexual bother
had returned to levels similar to those at baseline. No
differences between the intervention and control groups were
observed for anxiety, depression, emotional functioning, and
relational functioning.
Table 2. Participant characteristics*
Intervention Control
Couples
(n ¼ 21)
Patients
(n ¼ 21)
Partners
(n ¼ 21)
Couples
(n ¼ 22)
Patients
(n ¼ 22)
Partners
(n ¼ 22)
Age (y) at baseline,
range (mean)
55e76 (64.15) — 44e77 (63.27) —
Deprivation quintile
1 (highest) 1 1
2 2 2
3 5 3
4 3 4
5 (lowest) 10 11
Mean 3.90 4.05
Median 4 5
Mode 5 5
Time since surgery (mo),
range (mean)
2e23 (10.67) — 2e46 (12.82) —
Length of relationship (y),
range (mean)
10e51 (35.62) 1e52 (28.64)
Clinical risk
Low 6 — 5 —
Intermediate 13 — 13 —
High 2 — 3 —
White ethnicity, % 100 100 100 100
*P values are reported in Table 3.
J Sex Med 2016;-:1e10
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Acceptability and Feasibility
The trial processes were feasible, reﬂected in adequate
recruitment and retention rates of 38% and 74%, respec-
tively.44,46 Randomization worked well, with comparable groups
at baseline (Table 3). Clinically meaningful improvement in
outcome measurements was achieved for the EPIC (sexual bother
domain). A more sensitive and speciﬁc measurement of couple
relationship would be beneﬁcial to replace the SCORE-15 to
assess couple communication and relational functioning.
An average of 4.43 sessions was attended (range ¼ 1e6,
mode ¼ 6). Although the manual stated that sessions should be
scheduled every 2 to 3 weeks, every 3 to 4 weeks was a more
acceptable timeframe for couples and practitioners. For the 14
couples who attended all six sessions of the support, the average
time it took to complete the intervention was 135.43 days (w19
weeks, range ¼ 60e254 days).
Completed adherence checklists demonstrated a good level of
ﬁdelity to the manual (Table 5), and practitioners reported that
the training on delivery of the intervention was acceptable.
The ﬁrst and ﬁnal sessions had the highest adherence ratings
(mean adherence ¼ 8.87 and 8.78, respectively); session 4 had
the lowest overall rating of adherence (mean ¼ 7.38). Two
components of the intervention were less well addressed: role of
orgasm in sexual activity and sensate focus, which was covered in
session 4. Mean adherence ratings for role of orgasm (4.71) and
sensate focus (5.14) were signiﬁcantly below the mean adherence
rating (8.18). Postintervention interviews with practitioners
indicated that some couples were unwilling to have sexually
focused discussion owing to an absence of sexual activity before
the cancer treatment. Despite these reported challenges, the
adherence ratings for role of orgasm and sensate focus ranged
from 0 to 10, showing that the difﬁculty in delivering and dis-
cussing these topics was not universal. These results suggest that
the content and number of intervention sessions should be
guided by existing relational dynamics, including the level and
type of sexual activity before cancer treatment. Accordingly, the
manual would beneﬁt from further nuanced guidance on how
and when to engage and explore such issues with couples.
The integrated process evaluation did not identify any other
implementation problems of note. Hence, the study design and
content appear to have met predeﬁned feasibility criteria as
described in the Methods section subject to more detailed
guidance in the manual on how to explore pre-existing sexual
activity to determine the appropriate level of sexually focused
discussion with the couple.
Sample Size Calculation for a Deﬁnitive Trial
Preliminary statistical analysis suggests a future deﬁnitive
trial of a reﬁned intervention should assume a small effect size
(f ¼ 0.10) on the primary outcome at follow-up. Using the
between-within interaction in a repeated-measures analysis of
variance with two groups, three points of measurement and a
0.50 correlation between repeated measures, a total sample size of
214 would be required to have 90% power to detect this small
effect (f ¼ 0.10) at an a level of 0.05.
DISCUSSION
Results from this feasibility and pilot trial suggest that this
novel intervention has clinical beneﬁts in lessening distress related
to sexual function in the short term. This improvement is
particularly notable when evidence indicates that sexual bother
after prostatectomy tends to level off only at 36 months after
surgery.47 The improvement was not maintained at 6 months, so
couples might need continuing support to maintain the beneﬁts
gained by the end of intervention. Other psychosexual in-
terventions in prostate cancer have similarly lacked sustained
effects,23,34 although there have been promising results for
breast and gynecologic cancers.48 With many men exhibiting
difﬁculty adjusting to long-term functional loss,7 ongoing psy-
chosocial support might be required to support the emotional
consequences of erectile dysfunction. Although recruitment
focused on postsurgical patients, men receiving other treatments
affecting psychosexual and relational functioning, such as radio-
therapy or brachytherapy, also could beneﬁt from this approach.49
The study sought to match, or exceed, published recruitment
and retention rates as cited in the literature of couple psycho-
sexual interventions, which are 29% and 72%, respectively.44,46
The study surpassed this expectation with 38% couples
recruited and 74% retained in the study. The retention rate
(74%) is comparable to those reported in a systematic review of
dyadic (although not psychosexual) health interventions
(77.5%).50 This good retention rate might be resultant from the
communication the research team maintained through the study
with patients and partners. The process aimed to check ongoing
consent and, as a consequence of the personal contact, establish
positive relationships between participants and the project team.
The low rate of enrollment for those 2 to 4 years after surgery
Table 3. Baseline equivalence of patients
Test Intervention Control P values
t
Patient age (y), mean 64.15 63.27 .723
SIMD quintile, mean 3.90 4.05 .714
Years with partner, mean 35.62 28.77 .104
Months since surgery, mean 10.67 12.82 .456
c
2
Risk categorization, % .865
Low 28.6 23.8
Medium 61.9 61.9
High 9.5 14.3
Education, % .258
School 38.1 31.8
College 23.8 36.4
University 38.1 31.8
SIMD ¼ Scottish Index of Multiple Deprivation.
J Sex Med 2016;-:1e10
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indicates that limiting the timeframe to less than 2 years after
surgery would be more suitable, while making efforts to recruit
couples as soon as possible after they have recovered from the
immediate effects of surgery. Although addressing psychosexual
needs might not be an immediate priority for couples, the results
of this pilot study indicate that the intervention should be
delivered within a limited period before long-term adaptation has
commenced. The importance of offering support soon after
surgery reﬂects evidence that the sexual side effects of surgery are
immediate and troublesome51 and men express a desire for early
treatment to tackle these effects.52 Time since surgery has not
been reported in other studies that have been successful in
delivering short-term beneﬁts after a couple-focused psychosexual
intervention.23,24,34 However, this aspect of participant charac-
teristics is an important variable that should be analyzed in future
trials to improve recruitment and retention and to understand
how the efﬁcacy of interventions might be enhanced, particularly
to extend beneﬁts longer term.
The lower adherence ratings for the sexually focused aspects of
the treatment suggest that the intervention could be strengthened
with more detailed information about ways to engage couples in
sex-focused discussions, including techniques from sex therapy.
Practitioners reported that some couples were unwilling to engage
in sex-focused discussion, particularly if sexual activity had been
absent before cancer treatment. These data suggest that further
training and more speciﬁc guidance in the manual would be
beneﬁcial to strengthen the intervention’s focus on the sexual
relationship. This might include grieving the loss of the sexual
relationship and the physical sequelae of cancer treatment.53 In
intimacy-enhancing interventions for couples affected by prostate
cancer, Manne et al28 found that treatment effects were moder-
ated by baseline levels of individual distress and relational char-
acteristics, whereas Schover et al54 established that a partner’s
baseline level of sexual function inﬂuenced the efﬁcacy of the
intervention for men. Such evidence would suggest that future
trials should measure pre-existing levels of relational intimacy,
including sexual intimacy, within the couple, and partners’
baseline level of sexual function, ﬁrst, to assist practitioners in
framing sex-focused discussions and, second, to establish whether
this aspect of the couple’s relationship mediates intervention
outcomes in addition to therapeutic processes. Assessments such
as the Personal Assessment of Intimacy in Relationships55 com-
plemented by the Dyadic Adjustment Scale,56 as used by Manne
et al28 to compare levels of intimacy and relational satisfaction
before and after treatment, could be an alternative to the SCORE-
15 given its lack of sensitivity for measuring relational functioning
in the present study. In addition, the International Index of
Erectile Function,57 as adopted by Canada et al23 and Titta et al24
in their intervention studies, could be used in addition to the
EPIC to understand levels of bother and distress in the context of
sexual intercourse to provide a fuller picture of baseline sexual
functioning in the couple. The Female Sexual Function Index58
could be used to understand the efﬁcacy of the intervention in
relation to the partner’s sexual function before the intervention.Ta
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LIMITATIONS
This was a small-scale single-site study. The intervention was
delivered by clinicians with a mixture of modalities, rather than
solely systemic and/or psychosexual. Use of a mixed therapist
cohort reﬂected an innovative approach on the team’s part to
meet the demand of increasing numbers of men diagnosed with
prostate cancer and the existing pressure on existing psychosexual
services in the United Kingdom. Because most of these practi-
tioners were not familiar with sex therapy techniques before the
intervention, this might have inﬂuenced adherence to the sex-
focused part of the manual. Given the beneﬁts associated with
interventions that have sexual functioning as a major focus,23,24
recruiting clinicians with experience of sex therapy could have
improved the intervention’s efﬁcacy.
Participants varied considerably in time since surgery.
Compliance and motivation are likely to be moderated by time
since treatment. However, with a small sample it was not possible
to analyze any such effect on outcomes. The limited number of
same-sex couples and racial diversity in this sample also must be
acknowledged and a future trial should attempt to recruit a
broader and more proportionate sample of participants to test
aspects of social difference (eg, sexuality, age, cultural back-
ground, or socioeconomic status) that might affect the process or
outcome of the intervention.
Future larger trials would beneﬁt from objective assessment of
manual ﬁdelity through audio recording of sessions assessed by
independent raters. Moreover, although blinded randomization
was not possible in the present study—and is challenging in
principle for psychosocial interventions59—a deﬁnitive trial
would beneﬁt from an attention placebo control to understand
the effects of the psychosexual components more clearly.
Administering the EPIC in its entirety might not be meth-
odologically or ethically sound in future studies, because there
was very little change on global scores, with participants
reporting relatively high functioning on the three other summary
domains (urinary, bowel, and hormonal). Future studies should
consider administering only the sexual domain of this outcome
measurement and complementing the measurement with the
International Index of Erectile Function. The SCORE-15 lacked
speciﬁcity for this intervention, so a couple-focused outcome
measurement such as the Personal Assessment of Intimacy in
Relationships and the Dyadic Adjustment Scale would be
appropriate for future studies.
CONCLUSIONS
This novel feasibility study of a psychosexual intervention shows
promise in lessening distress associated with changes in sexual
function after surgery for prostate cancer. These ﬁndings indicate
the value of combining a family-systems approach with elements of
sex therapy to address broader relational issues that affect sexual
function. The clinically signiﬁcant impact on sexual bother imme-
diately after couple therapy indicates that the intervention would
beneﬁt from further development to extend beneﬁts.
Because improvements in sexual bother were not maintained
at longer-term follow-up, the intervention should be adapted to
provide more extended support for couples. More sensitive and
speciﬁc measurements of couple communication and relational
functioning should replace the SCORE-15 in future trials. With
a low recruitment rate of men 2 to 4 years after surgery, a
deﬁnitive trial should be targeted at men who have recovered
from the immediate side effects of surgery but who are no more
than 2 years past surgery.
Future trials should aim to recruit more same-sex couples and a
more ethnically and socially diverse participant group to increase
the generalizability of any results. The manual could be enhanced
with further information about how and when to engage couples
in discussing techniques from sex therapy, particularly when there
has been an absence of sexual activity before cancer treatment.
Overall, the study adds to the literature on psychosexual in-
terventions for men with prostate cancer by demonstrating the
efﬁcacy of a manual-based intervention for minimizing sexual
bother, particularly for men within 2 years of surgery, and
highlighting the importance of understanding the couple’s levels
of sexual activity before surgery to contextualize and deliver the
sexually focused aspects of treatment within a broader family-
systems model.
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Table 5. Average adherence of practitioners to treatment manual across intervention sessions
Practitioner (couples seen)
Session 1
(n ¼ 19)
Session 2
(n ¼ 16)
Session 3
(n ¼ 15)
Session 4
(n ¼ 14)
Session 5
(n ¼ 14)
Session 6
(n ¼ 14) Total
Practitioner 1 (n ¼ 1) 8.43 7.86 8.17 7.45 8 8.67 8
Practitioner 2 (n ¼ 2) 10 10 8 8.60 8.17 9.17 9
Practitioner 3 (n ¼ 5) 9 8.71 8.83 8.23 7.62 9 8.8
Practitioner 4 (n ¼ 6) 8.04 7.83 8.2 6.67 7.37 8.3 7.3
Practitioner 5 (n ¼ 1) 10 7.29 8.5 10 10 10 9.4
Practitioner 6 (n ¼ 4) 9.21 8.48 8.56 6.15 7.52 8.89 8.4
Total 8.87 8.41 8.39 7.38 7.77 8.78 8.5
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